Frequent travelers and rate of spread of epidemics

T Déirdre Hollingsworth, Neil M Ferguson, Roy M Anderson, T Déirdre Hollingsworth, Neil M Ferguson, Roy M Anderson

Abstract

A small proportion of air travelers make disproportionately more journeys than the rest of travelers. They also tend to interact predominantly with other frequent travelers in hotels and airport lounges. This group has the potential to accelerate global spread of infectious respiratory diseases. Using an epidemiologic model, we simulated exportation of cases from severe acute respiratory syndrome-like and influenza-like epidemics in a population for which a small proportion travel more frequently than the rest. Our simulations show that frequent travelers accelerate international spread of epidemics only if they are infected early in an outbreak and the outbreak does not expand rapidly. If the epidemic growth rate is high, as is likely for pandemic influenza, heterogeneities in travel are frequently overwhelmed by the large number of infected persons in the majority population and the resulting high probability that some of these persons will take an international flight.

Figures

Figure 1
Figure 1
Schematic representation of the model structure. Black boxes represent infectious stages and arrows indicate that persons in these populations are allowed to fly. A) Severe acute respiratory syndrome. Persons with latent infections are not infectious, and all infectious persons are symptomatic and prevented from traveling. B) Pandemic influenza. Persons with latent infections are infectious, and a proportion (1 – s) of infectious persons are asymptomatic and allowed to travel (indicated by the dotted arrows). The size of the arrows indicates that the persons in the high-frequency flier group have a higher probability of flying per day.
Figure 2
Figure 2
Mean number of cases exported from a single simulated source epidemic for severe acute respiratory syndrome–like parameters (A) and influenza-like parameters (B) (50,000 runs; parameters are listed in Table 1). Results are shown for a population in which everyone travels equally frequently (homogeneous model, circles), for a population in which 1% travel 20 times more frequently than the rest of the population, and for the 2 populations mixed randomly (Φ = 1, squares) for moderate levels of mixing between the groups (Φ = 0.5, diamonds) and for low levels of mixing in which most contacts are assortative (Φ = 0.25, triangles). The first cases are either in the majority population of low-frequency fliers (solid symbols) or high-frequency fliers (open symbols). Inset in B shows a greater range on the y-axis. Variability about these means is shown in Table 2 and Appendix Figure 1.

References

    1. Denstadli JM. Analysing air travel: a comparison of different survey methods and data collection procedures. J Travel Res. 2000;39:4–10. 10.1177/004728750003900102
    1. Office for National Statistics. Travel trends 2004: a report on the international passenger survey. Basingstoke (UK): Palgrave Macmillan; 2005.
    1. Severe Acute Respiratory Syndrome (SARS) Expert Committee. SARS in Hong Kong: from experience to action: severe acute respiratory syndrome (SARS). Expert Committee of Hong Kong. 2003. [cited 2007 Jun 21]. Available from
    1. Hufnagel L, Brockmann D, Geisel T. Forecast and control of epidemics in a globalized world. Proc Natl Acad Sci U S A. 2004;101:15124–9. 10.1073/pnas.0308344101
    1. Guimera R, Mossa S, Turtschi A, Amaral LA. The worldwide air transportation network: anomalous centrality, community structure, and cities’ global roles. Proc Natl Acad Sci U S A. 2005;102:7794–9. 10.1073/pnas.0407994102
    1. Colizza V, Barrat A, Barthelemy M, Vespignani A. The role of the airline transportation network in the prediction and predictability of global epidemics. Proc Natl Acad Sci U S A. 2006;103:2015–20. 10.1073/pnas.0510525103
    1. Pitman RJ, Cooper BS, Trotter CL, Gay NJ, Edmunds WJ. Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ. 2005;331:1242–3. 10.1136/bmj.38573.696100.3A
    1. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ. Delaying the international spread of pandemic influenza. PLoS Med. 2006;3:e212. 10.1371/journal.pmed.0030212
    1. Hollingsworth TD, Ferguson NM, Anderson RM. Will travel restrictions control the international spread of pandemic influenza? Nat Med. 2006;12:497–9. 10.1038/nm0506-497
    1. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442:448–52. 10.1038/nature04795
    1. Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med. 2006;3:e401. 10.1371/journal.pmed.0030401
    1. Colizza V, Barrat A, Barthelemy M, Valleron AJ, Vespignani A. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Med. 2007;4:e13. 10.1371/journal.pmed.0040013
    1. Donnelly CA, Fisher MC, Fraser C, Ghani AC, Riley S, Ferguson NM, et al. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004;4:672–83. 10.1016/S1473-3099(04)01173-9
    1. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, Meeyai A, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437:209–14. 10.1038/nature04017
    1. Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, et al. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004;359:1091–105. 10.1098/rstb.2004.1490
    1. Yu F, Le MQ, Inoue S, Thai HT, Hasebe F, Del Carmen Parquet M, et al. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2005;12:848–54.
    1. Wilder-Smith A, Teleman MD, Heng BH, Earnest A, Ling AE, Leo YS. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis. 2005;11:1142–5.
    1. Leung GM, Lim WW, Ho LM, Lam TH, Ghani AC, Donnelly CA, et al. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect. 2006;134:211–21. 10.1017/S0950268805004826
    1. Leung GM, Chung PH, Tsang T, Lim W, Chan SK, Chau P, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004;10:1653–6.
    1. Lee PP, Wong WH, Leung GM, Chiu SS, Chan KH, Peiris JS, et al. Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong. Pediatrics. 2006;117:e1156–62. 10.1542/peds.2005-1476
    1. Centers for Disease Control and Prevention. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders—Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:986–7.
    1. Longini IM Jr, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, et al. Containing pandemic influenza at the source. Science. 2005;309:1083–7. 10.1126/science.1115717
    1. Germann TC, Kadau K, Longini IM Jr, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006;103:5935–40. 10.1073/pnas.0601266103
    1. Bell DM; World Health Organization Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006;12:81–7.

Source: PubMed

3
订阅